Thalys Sampaio Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thalys Sampaio Rodrigues has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Anoop N. Koshy
Department of Cardiology Austin Health Melbourne Victoria Australia
4 shared publications- Anoop Ninan Koshy
The University of Melbourne Clinical School, Austin Health, Department of Cardiology, Melbourne, Victoria, Australia
4 shared publications - Louise M. Burrell
Department of Medicine, The University of Melbourne, Austin Health, Victoria, Australia
4 shared publications - Laurence Weinberg
Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia
3 shared publications Omar Farouque
Department of Cardiology, Austin Health, Melbourne, Victoria, Australia
3 shared publications- Omar Farouque
The University of Melbourne Clinical School, Austin Health, Department of Cardiology, Melbourne, Victoria, Australia
3 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Wiley in Internal Medicine Journal
Epidemiology and health burden of infective endocarditis: a comparative analysis of Australian vs global trends from 1990 to 2021
Background: Infective endocarditis (IE) is an uncommon but life‐threatening disease with evolving patient risk profiles and management strategies. However, its impact on the Australian healthcare system has not been described. Aims: To quantify the healthcare burden of IE in Australia over time in the past three decades and compare outcomes with global and high‐income settings. Methods: Data extracted from Global Burden of Disease 2021 included IE prevalence, mortality, disability‐adjusted life years (DALY), and heart failure (HF) attributed to IE from 1990 to 2021. Each metric was further indexed to age‐adjusted prevalence and expressed as summary rates per 100 IE cases (e.g. prevalence‐adjusted mortality rate), and were stratified by geographical groups (Australia, Global and High‐Income), sex and 5‐year age groups. Results: Between 1990 and 2021, 8 563 131 IE cases were reported worldwide, with 0.74% occurring in Australia. In Australia, age‐adjusted prevalence rates of IE (AAPR) quadrupled over time (AAPR AUS : 2.63–10.18 per 100 000 persons), whilst prevalence‐adjusted mortality rates (PAMR) and disability rates (PADR) declined (PAMR AUS : 18.6–11.25 deaths per hundred cases; PADR AUS : 440–244 DALY per hundred cases). Australia reported a growth in prevalence‐adjusted heart failure rates (PAHR AUS : 68.4–86.8 HF per hundred IE cases). Across all geographical groups, including Australia, bimodal peaks in mortality and disability affected middle‐aged (40–64 years) and elderly populations (≥75 years). IE prevalence was relatively even between sexes; males experienced higher IE mortality and disability, while females experienced a greater burden of heart failure. Conclusions: Australia's IE profile is distinct, with a sharper rise in prevalence and IE‐associated heart failure, despite declining mortality and disability. These findings suggest improved survival but increasing chronic morbidity, underscoring the need for enhanced post‐acute care models and further research to explore underlying drivers, including evolving risk factors, healthcare access and long‐term cardiac outcomes.
- 1 October 2026
- Published by Wiley in Internal Medicine Journal
Open AccessEpidemiology and health burden of infective endocarditis: a comparative analysis of Australian vs global trends from 1990 to 2021
Background: Infective endocarditis (IE) is an uncommon but life‐threatening disease with evolving patient risk profiles and management strategies. However, its impact on the Australian healthcare system has not been described. Aims: To quantify the healthcare burden of IE in Australia over time in the past three decades and compare outcomes with global and high‐income settings. Methods: Data extracted from Global Burden of Disease 2021 included IE prevalence, mortality, disability‐adjusted life years (DALY), and heart failure (HF) attributed to IE from 1990 to 2021. Each metric was further indexed to age‐adjusted prevalence and expressed as summary rates per 100 IE cases (e.g. prevalence‐adjusted mortality rate), and were stratified by geographical groups (Australia, Global and High‐Income), sex and 5‐year age groups. Results: Between 1990 and 2021, 8 563 131 IE cases were reported worldwide, with 0.74% occurring in Australia. In Australia, age‐adjusted prevalence rates of IE (AAPR) quadrupled over time (AAPR AUS : 2.63–10.18 per 100 000 persons), whilst prevalence‐adjusted mortality rates (PAMR) and disability rates (PADR) declined (PAMR AUS : 18.6–11.25 deaths per hundred cases; PADR AUS : 440–244 DALY per hundred cases). Australia reported a growth in prevalence‐adjusted heart failure rates (PAHR AUS : 68.4–86.8 HF per hundred IE cases). Across all geographical groups, including Australia, bimodal peaks in mortality and disability affected middle‐aged (40–64 years) and elderly populations (≥75 years). IE prevalence was relatively even between sexes; males experienced higher IE mortality and disability, while females experienced a greater burden of heart failure. Conclusions: Australia's IE profile is distinct, with a sharper rise in prevalence and IE‐associated heart failure, despite declining mortality and disability. These findings suggest improved survival but increasing chronic morbidity, underscoring the need for enhanced post‐acute care models and further research to explore underlying drivers, including evolving risk factors, healthcare access and long‐term cardiac outcomes.
- Open Access
- 4 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Conduction system pacing vs. biventricular pacing for cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis considering randomized controlled trials and observational studies
Aims: Biventricular pacing (BiVP) is the gold standard for cardiac resynchronization therapy (CRT) in heart failure with reduced ejection fraction (HFrEF), yet up to 30% of patients fail to respond. Conduction system pacing (CSP) has emerged as an alternative with potential for physiological superiority. Multiple 2026 multicentre randomized controlled trials (RCTs) reported contradictory results, necessitating an updated meta-analysis. This analysis aims to compare the safety and efficacy of CSP vs. BiVP for CRT in patients with HFrEF. Methods and results: PubMed, Cochrane CENTRAL, and Embase were searched (January 2010–May 2026) for RCTs and observational studies. Pooled risk ratios (RRs) and mean differences (MDs) were estimated using random-effects restricted maximum likelihood models. Twenty-five studies (11 RCTs, n = 1201; 14 observational, n = 3376) involving 4577 participants were included. In the RCT-only analysis, no significant differences were found in all-cause mortality (RR 0.96; P = 0.91), heart failure (HF) hospitalization (RR 0.67; P = 0.12), or procedural complications (RR 0.83; P = 0.44). Conduction system pacing significantly shortened paced QRS duration (MD −19.52 ms, P < 0.001) and improved New York Heart Association (NYHA) class (MD −0.19, P = 0.05). Combined analysis showed larger effect sizes, including lower all-cause mortality (RR 0.74; P = 0.004) and HF hospitalization (RR 0.64; P < 0.001) in the CSP group. Conclusion: Randomized evidence demonstrates no significant difference between CSP and BiVP in hard clinical endpoints, despite superior electrical resynchronization and modest functional improvement with CSP. Confirmation of any clinical superiority of CSP awaits adequately powered trials reporting objective outcomes.
- 4 August 2026
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (8)
Open AccessConduction system pacing vs. biventricular pacing for cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis considering randomized controlled trials and observational studies
Aims: Biventricular pacing (BiVP) is the gold standard for cardiac resynchronization therapy (CRT) in heart failure with reduced ejection fraction (HFrEF), yet up to 30% of patients fail to respond. Conduction system pacing (CSP) has emerged as an alternative with potential for physiological superiority. Multiple 2026 multicentre randomized controlled trials (RCTs) reported contradictory results, necessitating an updated meta-analysis. This analysis aims to compare the safety and efficacy of CSP vs. BiVP for CRT in patients with HFrEF. Methods and results: PubMed, Cochrane CENTRAL, and Embase were searched (January 2010–May 2026) for RCTs and observational studies. Pooled risk ratios (RRs) and mean differences (MDs) were estimated using random-effects restricted maximum likelihood models. Twenty-five studies (11 RCTs, n = 1201; 14 observational, n = 3376) involving 4577 participants were included. In the RCT-only analysis, no significant differences were found in all-cause mortality (RR 0.96; P = 0.91), heart failure (HF) hospitalization (RR 0.67; P = 0.12), or procedural complications (RR 0.83; P = 0.44). Conduction system pacing significantly shortened paced QRS duration (MD −19.52 ms, P < 0.001) and improved New York Heart Association (NYHA) class (MD −0.19, P = 0.05). Combined analysis showed larger effect sizes, including lower all-cause mortality (RR 0.74; P = 0.004) and HF hospitalization (RR 0.64; P < 0.001) in the CSP group. Conclusion: Randomized evidence demonstrates no significant difference between CSP and BiVP in hard clinical endpoints, despite superior electrical resynchronization and modest functional improvement with CSP. Confirmation of any clinical superiority of CSP awaits adequately powered trials reporting objective outcomes.
- Open Access
- 15 July 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Transvenous Lead Extraction Versus Abandonment of non‐Infected, Superfluous Leads—A Meta‐Analysis and Systematic Review
Background: Managing non‐functional cardiac implantable electronic device (CIED) leads remains controversial. While extraction is standard for infection, it is unclear whether transvenous lead extraction (TLE) or lead abandonment (LA) provides superior outcomes for superfluous leads. Prophylactic TLE may prevent future infection or venous obstruction and avoid complex delayed extraction but carries immediate procedural risk. Conversely, LA avoids upfront risk, though retained leads may predispose to long‐term sequelae. Objectives: To compare procedural and clinical outcomes of TLE versus LA for non‐infected leads and assess how pre‐existing abandoned leads influence the risks of subsequent extraction. Methods: PubMed, Embase, OVID, and Cochrane were searched (2000–2025) for studies comparing TLE versus LA and TLE with versus without abandoned leads. Twenty‐three observational studies involving 65,760 patients were included. Data was extracted by two investigators using PRISMA guidelines. Primary outcomes included major complications, in‐hospital mortality, and clinical success, pooled as odds ratios with 95% confidence intervals using a random‐effects model. Subgroup and meta‐regression analyses were performed. Results: TLE was associated with significantly higher odds of major complications (OR 2.07, 95% CI 1.42–3.03) and in‐hospital mortality (OR 2.97, 95% CI 1.95–4.53) compared with LA, with no significant long‐term difference within limited follow‐up. Extraction of previously abandoned leads carried higher risks of major complications (OR 2.51), minor complications (OR 1.79), and mortality (OR 2.06), with lower clinical success (OR 0.24) than functional leads. Recent studies show improved TLE safety. Conclusion: While TLE carried higher immediate risks, measured long‐term outcomes were comparable; however, follow‐up was insufficient to capture late abandonment‐related sequelae. Extraction of previously abandoned leads carried markedly higher risk, supporting earlier extraction in appropriately selected patients.
- 15 July 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Open AccessTransvenous Lead Extraction Versus Abandonment of non‐Infected, Superfluous Leads—A Meta‐Analysis and Systematic Review
Background: Managing non‐functional cardiac implantable electronic device (CIED) leads remains controversial. While extraction is standard for infection, it is unclear whether transvenous lead extraction (TLE) or lead abandonment (LA) provides superior outcomes for superfluous leads. Prophylactic TLE may prevent future infection or venous obstruction and avoid complex delayed extraction but carries immediate procedural risk. Conversely, LA avoids upfront risk, though retained leads may predispose to long‐term sequelae. Objectives: To compare procedural and clinical outcomes of TLE versus LA for non‐infected leads and assess how pre‐existing abandoned leads influence the risks of subsequent extraction. Methods: PubMed, Embase, OVID, and Cochrane were searched (2000–2025) for studies comparing TLE versus LA and TLE with versus without abandoned leads. Twenty‐three observational studies involving 65,760 patients were included. Data was extracted by two investigators using PRISMA guidelines. Primary outcomes included major complications, in‐hospital mortality, and clinical success, pooled as odds ratios with 95% confidence intervals using a random‐effects model. Subgroup and meta‐regression analyses were performed. Results: TLE was associated with significantly higher odds of major complications (OR 2.07, 95% CI 1.42–3.03) and in‐hospital mortality (OR 2.97, 95% CI 1.95–4.53) compared with LA, with no significant long‐term difference within limited follow‐up. Extraction of previously abandoned leads carried higher risks of major complications (OR 2.51), minor complications (OR 1.79), and mortality (OR 2.06), with lower clinical success (OR 0.24) than functional leads. Recent studies show improved TLE safety. Conclusion: While TLE carried higher immediate risks, measured long‐term outcomes were comparable; however, follow‐up was insufficient to capture late abandonment‐related sequelae. Extraction of previously abandoned leads carried markedly higher risk, supporting earlier extraction in appropriately selected patients.
- 12 December 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (4) , 570-579
Peri‐operative risk of non‐cardiac surgery in patients with aortic stenosis: a systematic review and meta‐analysis
Summary: Introduction: Aortic stenosis is a risk factor for adverse outcomes following non‐cardiac surgery; however, existing data regarding peri‐operative morbidity and mortality in this patient cohort remain conflicted. This systematic review and meta‐analysis aimed to quantify the peri‐operative risks in patients with aortic stenosis undergoing non‐cardiac surgery. Methods: Following the development of our search strategy, we searched databases for relevant studies. The primary endpoint was all‐cause in‐hospital or 30‐day mortality associated with aortic stenosis in patients undergoing non‐cardiac surgery. Secondary endpoints included: myocardial infarction; heart failure; stroke; delirium; venous thromboembolism; and acute kidney injury. Results: Nineteen studies involving 100,486 patients were included. The estimated all‐cause mortality was 3.8% (95%CI 3.7–3.9%) for patients with any degree of aortic stenosis and 9.6% (95%CI 7.7–12.1%) for those with severe aortic stenosis. A meta‐analysis of 14 comparative studies involving 2,885,254 patients revealed significantly increased mortality in patients with aortic stenosis compared with those without aortic stenosis (relative risk 1.58, 95%CI 1.18–2.12, p < 0.001). Aortic stenosis was also associated with an elevated risk of postoperative myocardial infarction (relative risk 1.79, 95%CI 1.2–2.67, p < 0.001) and heart failure (relative risk 2.06, 95%CI 1.19–3.59, p < 0.001). Discussion: Aortic stenosis in patients undergoing non‐cardiac surgery is associated with a three‐fold relative increase in the risk of mortality. These results highlight the need for further delineation of which surgical procedures are associated with the greatest risk of poor peri‐operative outcomes to guide heightened surveillance protocols, optimised peri‐operative management and thresholds for pre‐operative intervention.
- 12 December 2025
- Published by Wiley in Anaesthesia
- Vol. 81 (4) , 570-579
Peri‐operative risk of non‐cardiac surgery in patients with aortic stenosis: a systematic review and meta‐analysis
Summary: Introduction: Aortic stenosis is a risk factor for adverse outcomes following non‐cardiac surgery; however, existing data regarding peri‐operative morbidity and mortality in this patient cohort remain conflicted. This systematic review and meta‐analysis aimed to quantify the peri‐operative risks in patients with aortic stenosis undergoing non‐cardiac surgery. Methods: Following the development of our search strategy, we searched databases for relevant studies. The primary endpoint was all‐cause in‐hospital or 30‐day mortality associated with aortic stenosis in patients undergoing non‐cardiac surgery. Secondary endpoints included: myocardial infarction; heart failure; stroke; delirium; venous thromboembolism; and acute kidney injury. Results: Nineteen studies involving 100,486 patients were included. The estimated all‐cause mortality was 3.8% (95%CI 3.7–3.9%) for patients with any degree of aortic stenosis and 9.6% (95%CI 7.7–12.1%) for those with severe aortic stenosis. A meta‐analysis of 14 comparative studies involving 2,885,254 patients revealed significantly increased mortality in patients with aortic stenosis compared with those without aortic stenosis (relative risk 1.58, 95%CI 1.18–2.12, p < 0.001). Aortic stenosis was also associated with an elevated risk of postoperative myocardial infarction (relative risk 1.79, 95%CI 1.2–2.67, p < 0.001) and heart failure (relative risk 2.06, 95%CI 1.19–3.59, p < 0.001). Discussion: Aortic stenosis in patients undergoing non‐cardiac surgery is associated with a three‐fold relative increase in the risk of mortality. These results highlight the need for further delineation of which surgical procedures are associated with the greatest risk of poor peri‐operative outcomes to guide heightened surveillance protocols, optimised peri‐operative management and thresholds for pre‐operative intervention.
- Open Access
- 10 June 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (7) , 103720
Trends in Percutaneous Closure of Atrial Septal Anomalies: Impact of Landmark Trials Over 20 Years
- 10 June 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (7) , 103720
Open AccessTrends in Percutaneous Closure of Atrial Septal Anomalies: Impact of Landmark Trials Over 20 Years
- Open Access
- 3 June 2025
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 31 (12) , 1522-1532
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients
Cardiovascular (CV) disease is a leading cause of postoperative mortality following liver transplantation (LT). The presence of abdominal aortic calcification (AAC) has been linked to CV events in the general population. We sought to investigate whether AAC on routine pre-transplant CT can improve the prediction of coronary artery disease, post-LT major adverse cardiovascular events (MACEs) or long-term mortality. Of 461 patients undergoing LT between 2010 and 2018, 318 were included in the analysis, among whom 81 had also undergone computed tomography coronary angiography. The extent of AAC was quantified with high AAC defined as a calcium score ≥500. High AAC was identified in 84/318 (26.4%) and demonstrated moderate correlation with coronary artery calcium score (CACS) ( r =0.52, p p =0.02). It was also associated with a significantly increased risk of 30-day MACE (OR 2.34, 95% CI 1.08–5.05, p =0.03) and long-term mortality (HR 2.45, 95% CI 1.18–5.06, p =0.02). Following multivariate analysis adjusting for pertinent CV risk factors, high AAC remained a strong independent predictor of MACE (OR 3.10, 95% CI 1.27–7.60, p =0.02). Addition of AAC to the Revised Cardiac Risk Index significantly improved model fit for predicting MACE outcomes ( p <0.01), while the absence of heavy AAC ruled out moderate-to-severe disease on CT coronary angiography with a negative predictive value of 97.0%. High AAC on routine CT scans was associated with a 3-fold increased risk of 30-day MACE post-LT and improved CV risk prediction compared to traditional indices. Quantification of AAC may offer a simple method of improving CV risk assessment in these patients.
- 3 June 2025
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 31 (12) , 1522-1532
Open AccessAbdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients
Cardiovascular (CV) disease is a leading cause of postoperative mortality following liver transplantation (LT). The presence of abdominal aortic calcification (AAC) has been linked to CV events in the general population. We sought to investigate whether AAC on routine pre-transplant CT can improve the prediction of coronary artery disease, post-LT major adverse cardiovascular events (MACEs) or long-term mortality. Of 461 patients undergoing LT between 2010 and 2018, 318 were included in the analysis, among whom 81 had also undergone computed tomography coronary angiography. The extent of AAC was quantified with high AAC defined as a calcium score ≥500. High AAC was identified in 84/318 (26.4%) and demonstrated moderate correlation with coronary artery calcium score (CACS) ( r =0.52, p p =0.02). It was also associated with a significantly increased risk of 30-day MACE (OR 2.34, 95% CI 1.08–5.05, p =0.03) and long-term mortality (HR 2.45, 95% CI 1.18–5.06, p =0.02). Following multivariate analysis adjusting for pertinent CV risk factors, high AAC remained a strong independent predictor of MACE (OR 3.10, 95% CI 1.27–7.60, p =0.02). Addition of AAC to the Revised Cardiac Risk Index significantly improved model fit for predicting MACE outcomes ( p <0.01), while the absence of heavy AAC ruled out moderate-to-severe disease on CT coronary angiography with a negative predictive value of 97.0%. High AAC on routine CT scans was associated with a 3-fold increased risk of 30-day MACE post-LT and improved CV risk prediction compared to traditional indices. Quantification of AAC may offer a simple method of improving CV risk assessment in these patients.
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (7) , e20250248
Preditores de Recorrência de Taquiarritmia Atrial após Ablação por Cateter: Impacto Socioeconômico em Países de Baixa e Média Renda
Ao Editor, Lemos com grande interesse o artigo de Ternes et al., recentemente publicado nos Arquivos Brasileiros de Cardiologia, juntamente com seu editorial elucidativo., Este estudo prospectivo, multicêntrico, do tipo coorte, realizado com pacientes consecutivos em três centros no Brasil, forneceu informações valiosas sobre os preditores de recorrência de arritmia atrial após primeira ablação por cateter. O estudo destacou o contexto clínico em um país de renda média e relatou desfechos semelhantes aos de países de alta renda. No entanto, [...] Ao Editor, Lemos com grande interesse o artigo de Ternes et al., recentemente publicado nos Arquivos Brasileiros de Cardiologia, juntamente com seu editorial elucidativo., Este estudo prospectivo, multicêntrico, do tipo coorte, realizado com pacientes consecutivos em três centros no Brasil, forneceu informações valiosas sobre os preditores de recorrência de arritmia atrial após primeira ablação por cateter. O estudo destacou o contexto clínico em um país de renda média e relatou desfechos semelhantes aos de países de alta renda. No entanto,
- 1 January 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (7) , e20250248
Open AccessPreditores de Recorrência de Taquiarritmia Atrial após Ablação por Cateter: Impacto Socioeconômico em Países de Baixa e Média Renda
Ao Editor, Lemos com grande interesse o artigo de Ternes et al., recentemente publicado nos Arquivos Brasileiros de Cardiologia, juntamente com seu editorial elucidativo., Este estudo prospectivo, multicêntrico, do tipo coorte, realizado com pacientes consecutivos em três centros no Brasil, forneceu informações valiosas sobre os preditores de recorrência de arritmia atrial após primeira ablação por cateter. O estudo destacou o contexto clínico em um país de renda média e relatou desfechos semelhantes aos de países de alta renda. No entanto, [...] Ao Editor, Lemos com grande interesse o artigo de Ternes et al., recentemente publicado nos Arquivos Brasileiros de Cardiologia, juntamente com seu editorial elucidativo., Este estudo prospectivo, multicêntrico, do tipo coorte, realizado com pacientes consecutivos em três centros no Brasil, forneceu informações valiosas sobre os preditores de recorrência de arritmia atrial após primeira ablação por cateter. O estudo destacou o contexto clínico em um país de renda média e relatou desfechos semelhantes aos de países de alta renda. No entanto,
- Open Access
- 17 October 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (46) , 4971-4972
Utility of mineralocorticoid receptor antagonists in reducing burden of atrial fibrillation
This commentary refers to ‘Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?’, by A. Oraii et al., https://doi.org/10.1093/eurheartj/ehae687 and the discussion piece ‘Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials’, by A. Oraii et al., https://doi.org/10.1093/eurheartj/ehad811.
- 17 October 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (46) , 4971-4972
Open AccessUtility of mineralocorticoid receptor antagonists in reducing burden of atrial fibrillation
This commentary refers to ‘Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?’, by A. Oraii et al., https://doi.org/10.1093/eurheartj/ehae687 and the discussion piece ‘Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials’, by A. Oraii et al., https://doi.org/10.1093/eurheartj/ehad811.